Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation

被引:113
作者
Martins-de-Souza, Daniel [1 ,2 ,3 ]
Gattaz, Wagner F. [1 ]
Schmitt, Andrea [4 ]
Novello, Jose C. [2 ]
Marangoni, Sergio [2 ]
Turck, Christoph W. [3 ]
Dias-Neto, Emmanuel [1 ,5 ]
机构
[1] Univ Sao Paulo, Lab Neurociencias, Inst Psiquiatria, Fac Med, BR-05403010 Sao Paulo, Brazil
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
[3] Univ Estadual Campinas, Dept Bioquim, Inst Biol, BR-13083970 Campinas, SP, Brazil
[4] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
基金
巴西圣保罗研究基金会;
关键词
ANTERIOR CINGULATE CORTEX; GENE-EXPRESSION; TEMPORAL CORTEX; AUDITORY HALLUCINATIONS; MICROARRAY ANALYSIS; PREFRONTAL CORTEX; BIPOLAR DISORDER; BRAIN PROTEINS; LINKAGE; MATTER;
D O I
10.1186/1471-244X-9-17
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Schizophrenia is likely to be a consequence of DNA alterations that, together with environmental factors, will lead to protein expression differences and the ultimate establishment of the illness. The superior temporal gyrus is implicated in schizophrenia and executes functions such as the processing of speech, language skills and sound processing. Methods: We performed an individual comparative proteome analysis using two-dimensional gel electrophoresis of 9 schizophrenia and 6 healthy control patients' left posterior superior temporal gyrus (Wernicke's area - BA22p) identifying by mass spectrometry several protein expression alterations that could be related to the disease. Results: Our analysis revealed 11 downregulated and 14 upregulated proteins, most of them related to energy metabolism. Whereas many of the identified proteins have been previously implicated in schizophrenia, such as fructose-bisphosphate aldolase C, creatine kinase and neuron-specific enolase, new putative disease markers were also identified such as dihydrolipoyl dehydrogenase, tropomyosin 3, breast cancer metastasis-suppressor 1, heterogeneous nuclear ribonucleoproteins C1/C2 and phosphate carrier protein, mitochondrial precursor. Besides, the differential expression of peroxiredoxin 6 (PRDX6) and glial fibrillary acidic protein (GFAP) were confirmed by western blot in schizophrenia prefrontal cortex. Conclusion: Our data supports a dysregulation of energy metabolism in schizophrenia as well as suggests new markers that may contribute to a better understanding of this complex disease.
引用
收藏
页数:8
相关论文
共 58 条
  • [41] Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia
    Middleton, FA
    Mirnics, K
    Pierri, JN
    Lewis, DA
    Levitt, P
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (07) : 2718 - 2729
  • [42] Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
    Mirnics, K
    Middleton, FA
    Marquez, A
    Lewis, DA
    Levitt, P
    [J]. NEURON, 2000, 28 (01) : 53 - 67
  • [43] A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia
    Mitelman, Serge A.
    Brickman, Adam M.
    Shihabuddin, Lina
    Newmark, Randall E.
    Hazlett, Erin A.
    Haznedar, M. Mehmet
    Buchsbaum, Monte S.
    [J]. NEUROIMAGE, 2007, 37 (02) : 449 - 462
  • [44] Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis
    Novikova, Svetlana I.
    He, Fang
    Cutrufello, Nicholas J.
    Lidow, Michael S.
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 23 (01) : 61 - 76
  • [45] Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia
    Nudmamud, S
    Reynolds, GP
    [J]. NEUROSCIENCE LETTERS, 2001, 304 (1-2) : 9 - 12
  • [46] Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
    Pennington, K.
    Beasley, C. L.
    Dicker, P.
    Fagan, A.
    English, J.
    Pariante, C. M.
    Wait, R.
    Dunn, M. J.
    Cotter, D. R.
    [J]. MOLECULAR PSYCHIATRY, 2008, 13 (12) : 1102 - 1117
  • [47] Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
    Prabakaran, S
    Swatton, JE
    Ryan, MM
    Huffaker, SJ
    Huang, JTJ
    Griffin, JL
    Wayland, M
    Freeman, T
    Dudbridge, F
    Lilley, KS
    Karp, NA
    Hester, S
    Tkachev, D
    Mimmack, ML
    Yolken, RH
    Webster, MJ
    Torrey, EF
    Bahn, S
    [J]. MOLECULAR PSYCHIATRY, 2004, 9 (07) : 684 - 697
  • [48] Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study
    Rajarethinam, RP
    DeQuardo, JR
    Nalepa, R
    Tandon, R
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (02) : 303 - 312
  • [49] Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study
    Sivagnanasundaram, Sinthuja
    Crossett, Ben
    Dedova, Irina
    Cordwell, Stuart
    Matsumoto, Izuru
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (10) : 1291 - 1305
  • [50] Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia
    Steffek, Amy E.
    McCullumsmith, Robert E.
    Haroutuman, Vahram
    Meador-Woodruff, James H.
    [J]. SCHIZOPHRENIA RESEARCH, 2008, 103 (1-3) : 71 - 82